Literature DB >> 2327967

Effect of hydroxycobalamin[c-lactam] on propionate and carnitine metabolism in the rat.

E P Brass1, R H Allen, L J Ruff, S P Stabler.   

Abstract

The administration in vivo of the cobalamin analogue hydroxycobalamin[c-lactam] inhibits hepatic L-methylmalonyl-CoA mutase activity. The current studies characterize in vivo and in vitro the hydroxycobalamin[c-lactam]-treated rat as a model of disordered propionate and methylmalonic acid metabolism. Treatment of rats with hydroxycobalamin[c-lactam] (2 micrograms/h by osmotic minipump) increased urinary methylmalonic acid excretion from 0.55 mumol/day to 390 mumol/day after 2 weeks. Hydroxycobalamin[c-lactam] treatment was associated with increased urinary propionylcarnitine excretion and increased short-chain acylcarnitine concentrations in plasma and liver. Hepatocytes isolated from cobalamin-analogue-treated rats metabolized propionate (1.0 mM) to CO2 and glucose at rates which were only 18% and 1% respectively of those observed in hepatocytes from control (saline-treated) rats. In contrast, rates of pyruvate and palmitate oxidation were higher than control in hepatocytes from the hydroxycobalamin[c-lactam]-treated rats. In hepatocytes from hydroxycobalamin[c-lactam]-treated rats, propionylcarnitine was the dominant product generated from propionate when carnitine (10 mM) was present. The addition of carnitine thus resulted in a 4-fold increase in total propionate utilization under these conditions. Hepatocytes from hydroxycobalamin[c-lactam]-treated rats were more sensitive than control hepatocytes to inhibition of palmitate oxidation by propionate. This inhibition of palmitate oxidation was partially reversed by addition of carnitine. Thus hydroxycobalamin[c-lactam] treatment in vivo rapidly causes a severe defect in propionate metabolism. The consequences of this metabolic defect in vivo and in vitro are those predicted on the basis of propionyl-CoA and methylmalonyl-CoA accumulation. The cobalamin-analogue-treated rat provides a useful model for studying metabolism under conditions of a metabolic defect causing acyl-CoA accretion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2327967      PMCID: PMC1131211     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  On the mechanism of the antiketogenic action of propionate and succinate in isolated rat liver mitochondria.

Authors:  M Ciman; C R. Rossi; N Siliprandi
Journal:  FEBS Lett       Date:  1972-04-15       Impact factor: 4.124

2.  Effect of vitamin B12 deprivation on the in vivo levels of coenzyme A intermediates associated with propionate metabolism.

Authors:  E P Frenkel; R L Kitchens; L B Hersh; R Frenkel
Journal:  J Biol Chem       Date:  1974-11-10       Impact factor: 5.157

3.  A method for the determination of carnitine in the picomole range.

Authors:  G Cederblad; S Lindstedt
Journal:  Clin Chim Acta       Date:  1972-03       Impact factor: 3.786

4.  Carnitine metabolism in the vitamin B-12-deficient rat.

Authors:  E P Brass; S P Stabler
Journal:  Biochem J       Date:  1988-10-01       Impact factor: 3.857

5.  Effects of branched chain alpha-ketoacids on the metabolism of isolated rat liver cells. II. Interactions with gluconeogenesis and urea synthesis.

Authors:  E Wałajtys-Rode; K E Coll; J R Williamson
Journal:  J Biol Chem       Date:  1979-11-25       Impact factor: 5.157

6.  Inhibition of oxidative metabolism by propionic acid and its reversal by carnitine in isolated rat hepatocytes.

Authors:  E P Brass; P V Fennessey; L V Miller
Journal:  Biochem J       Date:  1986-05-15       Impact factor: 3.857

7.  Interaction of malonyl-CoA and related compounds with mitochondria from different rat tissues. Relationship between ligand binding and inhibition of carnitine palmitoyltransferase I.

Authors:  S E Mills; D W Foster; J D McGarry
Journal:  Biochem J       Date:  1983-07-15       Impact factor: 3.857

8.  Effects of propionate and carnitine on the hepatic oxidation of short- and medium-chain-length fatty acids.

Authors:  E P Brass; R A Beyerinck
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

9.  Effect of carnitine on propionate metabolism in the vitamin B-12--deficient rat.

Authors:  E P Brass; L J Ruff
Journal:  J Nutr       Date:  1989-08       Impact factor: 4.798

10.  Assay of methylmalonic acid in the serum of patients with cobalamin deficiency using capillary gas chromatography-mass spectrometry.

Authors:  S P Stabler; P D Marcell; E R Podell; R H Allen; J Lindenbaum
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

View more
  7 in total

1.  Increased hepatic mitochondrial capacity in rats with hydroxy-cobalamin[c-lactam]-induced methylmalonic aciduria.

Authors:  S Krahenbuhl; D B Ray; S P Stabler; R H Allen; E P Brass
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

2.  Translation rates of isolated liver mitochondria under conditions of hepatic mitochondrial proliferation.

Authors:  E P Brass
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

3.  Mitochondrial dysfunction in mut methylmalonic acidemia.

Authors:  Randy J Chandler; Patricia M Zerfas; Sara Shanske; Jennifer Sloan; Victoria Hoffmann; Salvatore DiMauro; Charles P Venditti
Journal:  FASEB J       Date:  2008-12-16       Impact factor: 5.191

4.  Hepatic Effects of Pharmacological Doses of Hydroxy-Cobalamin[c-lactam] in Mice.

Authors:  Patrizia Haegler; David Grünig; Benjamin Berger; Luigi Terracciano; Stephan Krähenbühl; Jamal Bouitbir
Journal:  PLoS One       Date:  2017-01-30       Impact factor: 3.240

5.  Response of Human Glioblastoma Cells to Vitamin B12 Deficiency: A Study Using the Non-Toxic Cobalamin Antagonist.

Authors:  Zuzanna Rzepka; Jakub Rok; Mateusz Maszczyk; Artur Beberok; Justyna Magdalena Hermanowicz; Dariusz Pawlak; Dorota Gryko; Dorota Wrześniok
Journal:  Biology (Basel)       Date:  2021-01-19

Review 6.  Peculiarities of one-carbon metabolism in the strict carnivorous cat and the role in feline hepatic lipidosis.

Authors:  Adronie Verbrugghe; Marica Bakovic
Journal:  Nutrients       Date:  2013-07-19       Impact factor: 5.717

7.  Astrogliosis in an Experimental Model of Hypovitaminosis B12: A Cellular Basis of Neurological Disorders due to Cobalamin Deficiency.

Authors:  Zuzanna Rzepka; Jakub Rok; Justyna Kowalska; Klaudia Banach; Justyna Magdalena Hermanowicz; Artur Beberok; Beata Sieklucka; Dorota Gryko; Dorota Wrześniok
Journal:  Cells       Date:  2020-10-09       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.